Zepbound, Eli Lilly's weight-loss drug containing tirzepatide, is manufactured across several U.S. facilities as part of the company's massive expansion to meet surging demand.

Key U.S. Manufacturing Sites

Eli Lilly has poured billions into domestic production since 2020, committing over $16 billion to new plants amid global supply pressures. Here's the breakdown:

Site| Location| Details| Timeline
---|---|---|---
Lebanon Facility| Indiana (near Indianapolis)| Primary site for tirzepatide API; $9B total investment ($5.3B added in 2024); 900 jobs planned. 13| Construction started 2023; production begins 2026, ramps up through 2028. 3
Kenosha County Facility| Wisconsin| $3B expansion for injectable production like Zepbound; largest non-Indiana U.S. investment. 9| Acquired 2024; expansion ongoing. 9
Four New Plants| Undisclosed U.S. states| $27B investment announced Feb 2025; three for API, one for injectables; ~13,000 jobs. 5| Production in ~5 years (by 2030). 5

Forum Buzz and Rumors

Online discussions, like Reddit threads from 2025, speculate about overseas sourcing—some users claim vials labeled "from China," sparking debates on FDA standards. Experts counter that Lilly must disclose API origins, and all sites meet identical FDA specs regardless of location. No official confirmation of Chinese manufacturing for final product; focus remains U.S.-heavy amid Trump's 2025 tariff threats on pharma imports.

Trending Context (Jan 2026)

With Zepbound's supply still "tight" per Lilly updates, these expansions address shortages while rivaling compounded versions. Latest news highlights Indiana as the hub , but Wisconsin bolsters injectables—vital as prescriptions hit record highs last year. Picture this: From lab peptides in Indiana garages to billion-dollar factories, Zepbound's story mirrors biotech booms like Ozempic's rise.

TL;DR: Primarily Indiana (Lebanon) for API starting 2026, Wisconsin for injectables, plus upcoming U.S. sites—no confirmed non-U.S. final production.

Information gathered from public forums or data available on the internet and portrayed here.